Skip to main content

Daily Digest: Mired S.F. high-rise plans see reboot; Landlord faces eviction

Meanwhile, a South San Francisco-based developer of cardiometabolic medicines announced that it raised $190 million in Series A funding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.